Ana Santaballa Bertran

16PUBLICATIONS
101CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

|Dec 12, 2025
Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.

Miguel Martín, Ángel L Guerrero-Zotano, María E Pérez-López

|Mar 31, 2025
Sex and gender differences in cancer pathogenesis and pharmacology.

Beatriz Bernardez, Oliver Higuera, Virginia Martinez-Callejo

|Mar 28, 2025
Sex-related differences in the efficacy and toxicity of cancer treatments.

Ana Santaballa Bertrán, José Antonio Marcos Rodríguez, Ana Cardeña-Gutiérrez

Pageof 3